北海康成-B(01228)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01228 北海康成-B

未开盘 09-03 16:08:53

2.240

-0.050

-2.18%

最高2.380	最低2.190	成交量475.48万
今开2.280	昨收2.290	日振幅8.30%
总市值11.20亿	流通市值9.52亿	总股本5.00亿
成交额1,077万	换手率1.12%	流通股本4.25亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01228","market":"HK","secType":"STK","nameCN":"北海康成-B","latestPrice":2.24,"timestamp":1756886933152,"preClose":2.29,"halted":0,"volume":4754758,"delay":0,"floatShares":424838320,"shares":500000000,"eps":-1.1379443679010612,"marketStatus":"未开盘","change":-0.05,"latestTime":"09-03 16:08:53","open":2.28,"high":2.38,"low":2.19,"amount":10773588,"amplitude":0.082969,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.34992853670822904,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756949400000},"marketStatusCode":0,"adr":0,"listingDate":1639065600000,"exchange":"SEHK","adjPreClose":2.29,"openAndCloseTimeList":[[1756863000000,1756872000000],[1756875600000,1756886400000]],"volumeRatio":0.5098740991856087,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01228","defaultTab":"news","newsList":[{"id":"2564816873","title":"北海康成-B盘中异动 股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564816873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564816873?lang=zh_cn&edition=full","pubTime":"2025-09-02 13:22","pubTimestamp":1756790553,"startTime":"0","endTime":"0","summary":"2025年09月02日下午盘13时22分，北海康成-B股票出现异动，股价急速下跌5.06%。截至发稿，该股报2.250港元/股，成交量301.178万股，换手率0.60%，振幅8.02%。北海康成-B股票所在的生物技术行业中，整体涨幅为0.90%。其中，涨幅最大的是北海康成，其涨幅高达1644%，不过，尽管今年以来涨幅巨大，公司目前总市值仍然较小，仅有约11亿港元。截至5月底，中国创新药在海外MNC中 5000万美元以上首付款项目的比例已经提升至42%，而2020年仅为4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902132234a4aee557&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902132234a4aee557&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"1118447602","title":"异动解读 | 北海康成-B盘中大涨5.60%，中期业绩扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1118447602","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118447602?lang=zh_cn&edition=full","pubTime":"2025-09-01 09:32","pubTimestamp":1756690338,"startTime":"0","endTime":"0","summary":"周一盘中，北海康成-B股价大涨5.60%，引发市场关注。这一显著涨幅很可能与公司最新发布的中期业绩报告有关。根据北海康成-B发布的截至2025年6月30日止6个月中期业绩报告，公司成功实现扭亏为盈。报告显示，该期间内公司取得溢利5923.8万元人民币，而去年同期则录得亏损2.47亿元人民币。然而，值得注意的是，公司同期收益为2224.8万元人民币，同比下降50.33%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01228"],"gpt_icon":0},{"id":"2563588688","title":"北海康成-B(01228)发布中期业绩，期内溢利5923.8万元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2563588688","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563588688?lang=zh_cn&edition=full","pubTime":"2025-08-31 18:13","pubTimestamp":1756635202,"startTime":"0","endTime":"0","summary":"智通财经APP讯，北海康成-B(01228)发布截至2025年6月30日止6个月中期业绩，该集团取得收益2224.8万元，同比减少50.33%;期内溢利5923.8万元，去年同期则取得亏损2.47亿元;每股盈利0.14元。公告称，收入减少主要由于本公司原计划于2021年战略性专注于罕见病，于2024年底贺俪安®分销协议终止后贺俪安®在台湾销售停止。除贺俪安®在台湾的销售外，我们的收益较2024年同期减少170万元或6.9%，主要由于2025年上半年北海康成实施积极存货管理，并在渠道中减少迈芮倍®的库存。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1339498.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"北海康成-B(01228)发布中期业绩，期内溢利5923.8万元 同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2562571033","title":"北海康成-B(01228)8月27日根据认购协议发行7497.15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2562571033","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562571033?lang=zh_cn&edition=full","pubTime":"2025-08-27 18:47","pubTimestamp":1756291679,"startTime":"0","endTime":"0","summary":"智通财经APP讯，北海康成-B(01228)发布公告，于2025年8月27日根据认购协议发行和配发每股1.34港元的认购股份7497.15万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1336362.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2562710389","title":"北海康成-B(01228)委任王廷伟为非执行董事及提名委员会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=2562710389","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562710389?lang=zh_cn&edition=full","pubTime":"2025-08-27 18:45","pubTimestamp":1756291511,"startTime":"0","endTime":"0","summary":"智通财经APP讯，北海康成-B(01228)发布公告，王廷伟先生已获委任为非执行董事及提名委员会成员，自2025年8月27日起生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1336358.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2562300107","title":"北海康成-B08月26日遭主力抛售373.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562300107","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562300107?lang=zh_cn&edition=full","pubTime":"2025-08-26 16:16","pubTimestamp":1756196161,"startTime":"0","endTime":"0","summary":"08月26日, 北海康成-B股价跌0.75%，报收2.64元，成交金额3521.0万元，换手率3.13%，振幅9.77%，量比0.75。北海康成-B今日主力资金净流出373.2万元，上一交易日主力净流出305.0万元。该股近5个交易日上涨30.05%，主力资金累计净流出81.9万元；近20日主力资金累计净流入1303.7万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250826171436a49fb8bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250826171436a49fb8bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2562216883","title":"港股异动 | 北海康成-B(01228)再涨超12% 公司获百洋医药战略投资 旗下三款产品通过商保创新药目录初审","url":"https://stock-news.laohu8.com/highlight/detail?id=2562216883","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562216883?lang=zh_cn&edition=full","pubTime":"2025-08-25 15:19","pubTimestamp":1756106359,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，北海康成-B再涨超12%，年内累计涨幅已接近20倍。消息面上，8月13日，北海康成宣布与百洋医药达成股份认购协议，根据协议，百洋医药将斥资1亿港元认购北海康成股份。与此同时，北海康成与百洋医药双方通过签订独家商业化服务协议，进一步深化战略协同。此外，2025年，国家医保局首次设立“商保创新药目录”，并于7月11日正式启动申报工作。市场人士称，通过初审名单，对于北海康成意义重大。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334373.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01228","159992","BK0250","301015","BK1161","06978","BK1574"],"gpt_icon":0},{"id":"2561426382","title":"港股异动 | 北海康成-B(01228)再涨近17% 年内累涨超15倍 公司近期获得百洋医药战略认购","url":"https://stock-news.laohu8.com/highlight/detail?id=2561426382","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561426382?lang=zh_cn&edition=full","pubTime":"2025-08-22 15:07","pubTimestamp":1755846473,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，北海康成-B再涨近17%，年内累计涨幅已超1500%。消息面上，北海康成近日公布，与百洋医药达成股份认购协议。百洋医药将以每股1.34港元的价格认购价值约1亿港元的北海康成股份。与此同时，北海康成与百洋医药双方通过签订独家商业化服务协议，进一步深化战略协同。根据协议，百洋医药旗下子公司将获得北海康成旗下特定产品在中国内地、香港及澳门地区的推广权。北海康成三款罕见病产品均通过了商保创新药目录的形式审查。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1333405.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301015","BK1161","01228","BK0250"],"gpt_icon":0},{"id":"2560156526","title":"港股异动 | 北海康成-B(01228)再涨近9% 旗下三款罕见病产品均通过商保创新药目录的形式审查","url":"https://stock-news.laohu8.com/highlight/detail?id=2560156526","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560156526?lang=zh_cn&edition=full","pubTime":"2025-08-19 11:03","pubTimestamp":1755572638,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，北海康成-B再涨近9%，截至发稿，涨3.47%，报2.09港元，成交额2027.73万港元。消息面上，国家医保局8月12日公布商保创新药目录初审名单。此外，北海康成近日公布，向百洋医药发行7497万股新股，每股作价1.34港元，较停牌前收报折让19.76%，认购事项所得款项净额约9866.18万港元，拟用于商业化产品的研发；营销及推广活动；偿还贷款融资；及日常营运。完成后，百洋医药将持有公司股本14.99%，后者已表示其无意于三年内收购公司任何控股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1331343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","159992","06978","01228"],"gpt_icon":0},{"id":"2559936506","title":"港股异动 | 北海康成-B(01228.HK)回落逾10% 近日拟折让约19.76%向百洋医药发行7497.15万股认购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2559936506","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559936506?lang=zh_cn&edition=full","pubTime":"2025-08-14 11:43","pubTimestamp":1755143024,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01228","301015","BK1161","BK0250"],"gpt_icon":0},{"id":"1187244558","title":"港股生物医药概念股强势拉升，中慧生物-B、北海康成-B涨超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=1187244558","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187244558?lang=zh_cn&edition=full","pubTime":"2025-08-13 10:01","pubTimestamp":1755050488,"startTime":"0","endTime":"0","summary":"8月13日，港股生物医药概念股强势拉升，$中慧生物-B(02627)$、$北海康成-B(01228)$涨超30%，$派格生物医药-B(02565)$涨近9%，$荃信生物-B(02509)$涨超6%。","market":"hk","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"eea96c2db952be4ad0141d428041d6b9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","02627","BK1161","01228","02565","09939"],"gpt_icon":0},{"id":"2559673115","title":"港股异动 | 北海康成-B(01228.HK)再涨超12% 公司向百洋医药发行新股 双方签订独家商业服务协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2559673115","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559673115?lang=zh_cn&edition=full","pubTime":"2025-08-13 09:41","pubTimestamp":1755049303,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01228","BK1161","BK0250","301015"],"gpt_icon":0},{"id":"2559962678","title":"北海康成-B(01228.HK)拟折让约19.76%发行7497.15万股认购股份 净筹约9866.18万港元 8月13日复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2559962678","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559962678?lang=zh_cn&edition=full","pubTime":"2025-08-13 09:02","pubTimestamp":1755046953,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2558285076","title":"北海康成-B(01228)附属拟委任百洋医药附属公司为独家合同销售组织以推广集团的若干产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2558285076","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558285076?lang=zh_cn&edition=full","pubTime":"2025-08-12 23:00","pubTimestamp":1755010851,"startTime":"0","endTime":"0","summary":"智通财经APP讯，北海康成-B(01228)发布公告，于2025年8月11日，集团的两家附属公司与青岛百洋医药股份有限公司(301015.SZ)(百洋医药)的一家附属公司(百洋附属公司)正式建立战略合作关系。上述各方已订立一份战略合作及独家商业服务协议，据此，相关附属公司已同意委任百洋附属公司为独家合同销售组织(CSO)，于中国内地、中国香港及中国澳门(相关地区)推广集团的若干产品，但须受集团相关成员公司与该等产品各自的授权方所订立的上游授权协议(包括(在适用情况下)相关授权方的同意)所规限。商业服务协议亦订明，百洋附属公司的联属公司可按百洋的选择担任该等产品于相关地区的分销商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1328796.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301015","01228","BK1161","BK0250"],"gpt_icon":0},{"id":"2558285676","title":"北海康成-B拟折让约19.76%发行7497.15万股认购股份 净筹约9866.18万港元 8月13日复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2558285676","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558285676?lang=zh_cn&edition=full","pubTime":"2025-08-12 22:59","pubTimestamp":1755010776,"startTime":"0","endTime":"0","summary":"每股认购股份1.34港元的认购价较股份于2025年8月11日在联交所所报的收市价每股1.67港元折让约19.76%。认购事项所得款项总额将为1亿港元，及经扣除就认购事项产生的相关开支后，公司根据认购事项应收所得款项净额估计约为9866.18万港元。公司已向联交所申请自2025年8月13日上午九时正起恢复股份于联交所买卖。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1328795.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2558694873","title":"北海康成-B(01228)8月12日上午9时正起短暂停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2558694873","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558694873?lang=zh_cn&edition=full","pubTime":"2025-08-12 09:20","pubTimestamp":1754961640,"startTime":"0","endTime":"0","summary":"智通财经APP讯，北海康成-B(01228)发布公告，于2025年8月12日上午9时正起短暂停牌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1328330.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2558917276","title":"北海康成-B8月12日起短暂停牌 待刊发内幕消息","url":"https://stock-news.laohu8.com/highlight/detail?id=2558917276","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558917276?lang=zh_cn&edition=full","pubTime":"2025-08-12 09:07","pubTimestamp":1754960835,"startTime":"0","endTime":"0","summary":"格隆汇8月12日丨北海康成-B(01228.HK)发布公告，公司股份将于2025年8月12日（星期二）上午九时正起在香港联交所暂停买卖，以待刊发一份载有公司内幕消息的公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081209072594ddbb93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081209072594ddbb93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2558915686","title":"北海康成制药有限公司在香港暂停交易。","url":"https://stock-news.laohu8.com/highlight/detail?id=2558915686","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558915686?lang=zh_cn&edition=full","pubTime":"2025-08-12 08:42","pubTimestamp":1754959322,"startTime":"0","endTime":"0","summary":"北海康成制药有限公司在香港暂停交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508120844329741d94d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508120844329741d94d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1161","BK1191","01228","BK1574"],"gpt_icon":0},{"id":"2558352626","title":"北海康成-B盘中涨超35%，年内累计涨幅已逾13倍！北海康成创始人：罕见病不同于常见病，光依靠保基本的国家医保很难解决患者的支付难题","url":"https://stock-news.laohu8.com/highlight/detail?id=2558352626","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558352626?lang=zh_cn&edition=full","pubTime":"2025-08-11 11:55","pubTimestamp":1754884555,"startTime":"0","endTime":"0","summary":"截至发稿，股价上涨31.85%，现报1.78港元，成交额4255.90万港元。7月3日，戈谢病一类创新药戈芮宁开出首张处方，首位患者已在新华医院接受治疗。北海康成创始人、董事长兼首席执行官表示，罕见病不同于常见病，光依靠保基本的国家医保很难解决患者的支付难题，北海康成正在积极与医保支付部门沟通，希望通过戈芮宁的案例，为新的更加可行的罕见病支付机制提供支撑，为中国罕见病商业化环境铺路开桥。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811115818974015dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811115818974015dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2558163841","title":"港股异动 | 北海康成-B(01228)再涨超35% 戈芮宁首张处方已落地 公司称正在积极与医保支付部门沟通","url":"https://stock-news.laohu8.com/highlight/detail?id=2558163841","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558163841?lang=zh_cn&edition=full","pubTime":"2025-08-11 10:23","pubTimestamp":1754879004,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，北海康成-B再涨超35%，年内累计涨幅已超13倍。7月3日，戈谢病一类创新药戈芮宁开出首张处方，首位患者已在新华医院接受治疗。北海康成创始人、董事长兼首席执行官表示，罕见病不同于常见病，光依靠保基本的国家医保很难解决患者的支付难题，北海康成正在积极与医保支付部门沟通，希望通过戈芮宁的案例，为新的更加可行的罕见病支付机制提供支撑，为中国罕见病商业化环境铺路开桥。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1327843.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01228"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ssitimber.com.hk","stockEarnings":[{"period":"1week","weight":-0.0508},{"period":"1month","weight":1.8354},{"period":"3month","weight":14.4483},{"period":"6month","weight":13.359},{"period":"1year","weight":7.1455},{"period":"ytd","weight":15.8421}],"compareEarnings":[{"period":"1week","weight":0.0056},{"period":"1month","weight":0.0247},{"period":"3month","weight":0.0601},{"period":"6month","weight":0.0459},{"period":"1year","weight":0.4358},{"period":"ytd","weight":0.2634}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"CANbridge Pharmaceuticals Inc是一家全球生物制药公司。该公司专注于罕见病转化疗法的研究、开发和商业化。该公司拥有一个药物组合，其中包括三种获批药物和八种资产的管线，针对尚未满足需求的罕见病适应症。这些包括亨特综合征和其他溶酶体贮积症、阵发性睡眠性血红蛋白尿和其他补体介导的疾病、血友病A、代谢性疾病、罕见胆汁淤积性肝病和神经肌肉疾病。其管线包括Hunterase、Livmarli、CAN106和CAN103。Hunterase是一种酶替代疗法，用于治疗II型粘多糖贮积症（MPS II），也称为亨特综合征。Livmarli是一种口服、吸收率极低、可逆性的回肠胆汁酸转运蛋白抑制剂，正在开发中，用于治疗罕见的胆汁淤积性肝病，包括Alagille综合征和进行性家族性肝内胆汁淤积症。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.179215},{"month":2,"riseRate":0.25,"avgChangeRate":0.001379},{"month":3,"riseRate":0.25,"avgChangeRate":-0.105397},{"month":4,"riseRate":0.25,"avgChangeRate":-0.006446},{"month":5,"riseRate":0,"avgChangeRate":-0.117685},{"month":6,"riseRate":0.25,"avgChangeRate":0.256405},{"month":7,"riseRate":0.5,"avgChangeRate":0.547002},{"month":8,"riseRate":0.25,"avgChangeRate":0.239858},{"month":9,"riseRate":0.5,"avgChangeRate":0.117333},{"month":10,"riseRate":0,"avgChangeRate":-0.130297},{"month":11,"riseRate":0,"avgChangeRate":-0.292964},{"month":12,"riseRate":0.333333,"avgChangeRate":0.002113}],"exchange":"SEHK","name":"北海康成-B","nameEN":"CANBRIDGE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"北海康成-B(01228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供北海康成-B(01228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"北海康成-B,01228,北海康成-B股票,北海康成-B股票老虎,北海康成-B股票老虎国际,北海康成-B行情,北海康成-B股票行情,北海康成-B股价,北海康成-B股市,北海康成-B股票价格,北海康成-B股票交易,北海康成-B股票购买,北海康成-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"北海康成-B(01228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供北海康成-B(01228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}